VolitionRx Launches rNuQ Webshop to Expand Product Range
VolitionRx Limited (VNRX) has launched its rNuQ webshop to offer a range of recombinant nucleosomes developed over the past decade. The webshop aims to provide researchers with high-quality, ready-to-use products and may generate new revenue as part of the company's commercialization strategy. The company also mentioned discussions with pharmaceutical firms for bespoke assay development.
Topics: commercialization epigenetics product launch research tools